A review of the bioavailability of cefadroxil.
作者信息
Santella P J, Henness D
出版信息
J Antimicrob Chemother. 1982 Sep;10 Suppl B:17-25. doi: 10.1093/jac/10.suppl_b.17.
PMID:7142089
Abstract
摘要
相似文献
1
A review of the bioavailability of cefadroxil.头孢羟氨苄生物利用度综述。
J Antimicrob Chemother. 1982 Sep;10 Suppl B:17-25. doi: 10.1093/jac/10.suppl_b.17.
2
Comparative human oral clinical pharmacology of cefadroxil, cephalexin, and cephradine.头孢羟氨苄、头孢氨苄和头孢拉定的人体口腔临床药理学比较
Antimicrob Agents Chemother. 1977 Feb;11(2):331-8. doi: 10.1128/AAC.11.2.331.
3
Comparative pharmacokinetics of cefadroxil, cefaclor, cephalexin and cephradine in infants and children.头孢羟氨苄、头孢克洛、头孢氨苄和头孢拉定在婴幼儿及儿童中的比较药代动力学
J Antimicrob Chemother. 1982 Sep;10 Suppl B:27-31. doi: 10.1093/jac/10.suppl_b.27.
4
[Oral bioavailability of cefadroxil: influence of food].头孢羟氨苄的口服生物利用度：食物的影响
Arch Farmacol Toxicol. 1982 Dec;8(3):171-8.
5
[Cefadroxil - fewer single administrations in better bioavailability].
ZFA (Stuttgart). 1981 Nov 10;57(31):2174-7.
6
Bioavailability of cefadroxil capsules and suspension in pediatric patients.头孢羟氨苄胶囊和混悬液在儿科患者中的生物利用度。
J Int Med Res. 1980;8(Suppl 1):9-14.
7
Cefadroxil. A review of its antibacterial, pharmacokinetic and therapeutic properties in comparison with cephalexin and cephradine.头孢羟氨苄。与头孢氨苄和头孢拉定相比，对其抗菌、药代动力学及治疗特性的综述。
Drugs. 1986;32 Suppl 3:1-16. doi: 10.2165/00003495-198600323-00003.
8
Influence of dosage form and administration route on the pharmacokinetic parameters of cefadroxil.剂型与给药途径对头孢羟氨苄药代动力学参数的影响。
Int J Clin Pharmacol Ther Toxicol. 1982 Feb;20(2):73-7.
9
Pharmacokinetics of the oral cephalosporins in adults.
J Int Med Res. 1980;8(Suppl 1):2-8.
10
Cefadroxil in the treatment of soft tissue infections.头孢羟氨苄治疗软组织感染。
J Int Med Res. 1980;8(Suppl 1):64-9.
引用本文的文献
1
In Vitro In Vivo Extrapolation and Bioequivalence Prediction for Immediate-Release Capsules of Cefadroxil Based on a Physiologically-Based Pharmacokinetic ACAT Model.基于生理药代动力学 ACAT 模型的头孢氨苄速释胶囊的体外-体内外推和生物等效性预测。
AAPS PharmSciTech. 2024 May 7;25(5):100. doi: 10.1208/s12249-024-02811-z.
2
Physiologically Based Pharmacokinetic Modeling of Cefadroxil in Mouse, Rat, and Human to Predict Concentration-Time Profile at Infected Tissue.头孢羟氨苄在小鼠、大鼠和人体中的生理药代动力学建模，以预测感染组织中的浓度-时间曲线。
Front Pharmacol. 2021 Dec 23;12:692741. doi: 10.3389/fphar.2021.692741. eCollection 2021.
3
In Silico Prediction of the Absorption and Disposition of Cefadroxil in Humans using an Intestinal Permeability Method Scaled from Humanized Mice.基于人源化小鼠的肠道通透性方法预测头孢羟氨苄在人体内的吸收和处置的计算研究。
Drug Metab Dispos. 2019 Mar;47(3):173-183. doi: 10.1124/dmd.118.084236. Epub 2018 Dec 28.
4
Species differences in the pharmacokinetics of cefadroxil as determined in wildtype and humanized PepT1 mice.在野生型和人源化PepT1小鼠中测定的头孢羟氨苄药代动力学的种属差异。
Biochem Pharmacol. 2016 May 1;107:81-90. doi: 10.1016/j.bcp.2016.03.008. Epub 2016 Mar 12.
5
Population pharmacokinetic modeling of cefadroxil renal transport in wild-type and Pept2 knockout mice.野生型和肽转运蛋白2基因敲除小鼠中头孢羟氨苄肾脏转运的群体药代动力学建模
Xenobiotica. 2016;46(4):342-9. doi: 10.3109/00498254.2015.1080881. Epub 2015 Sep 15.
6
Comparison of cefadroxil and cephalothin disk susceptibility test results.头孢羟氨苄与头孢噻吩纸片药敏试验结果的比较。
J Clin Microbiol. 1989 Jul;27(7):1460-3. doi: 10.1128/jcm.27.7.1460-1463.1989.
Zotero 插件